Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Myeloma Bispecific Antibody Research

Albert Oriol

MD, PhD

🏢Institut Catala d'Oncologia🌐Spain

Attending Physician, Hematology Department

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Albert Oriol is a clinical myeloma researcher who has contributed to multiple bispecific antibody registration trials in Europe. His work on real-world outcomes and infection management during bispecific therapy has improved clinical practice. He has been an advocate for equitable access to novel myeloma therapies across European healthcare systems.

Share:

🧪Research Fields 研究领域

Bispecific antibody access
Myeloma clinical trials
Real-world outcomes
Infection management bispecifics
Southern European myeloma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Albert Oriol 的研究动态

Follow Albert Oriol's research updates

留下邮箱,当我们发布与 Albert Oriol(Institut Catala d'Oncologia)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment